| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner | 10% Owner
4 companies
Denner Alexander J serves as a Director at INVA and has filed Form 4s across 4 companies. Across recent SEC filings that breaks down to 30 buys and 7 sells. Those positions are worth an estimated $99.1M at current prices.
Historically, Denner Alexander J's trades have earned a middling insider score of 66/100 across 13 rated trades. Over a 12-month horizon, 76.9% of those trades were profitable, with an average 12-month return of +8.9%.
The biggest single holding is INVA (~$99.1M). The recent filings there lean toward selling, a net 991,295 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 17, 2026 | IRWD Ironwood Pharmaceuticals, Inc. | Director | Sell | 6,730,800 | $3.05 | $20,530,448.00 | -42.3% | +13.5% | - | |
| Mar 6, 2025 | INVA Innoviva, Inc. | - | Sell | 1,618,295 | $17.55 | $28,395,442.43 | -22.2% | +18.7% | +25.3% | |
| Jun 15, 2023 | INVA Innoviva, Inc. | - | Buy | 62,000 | $13.13 | $814,196.40 | +0.9% | -5.1% | +20.8% | |
| Jun 6, 2023 | INVA Innoviva, Inc. | - | Buy | 15,000 | $13.05 | $195,680.80 | +0.2% | -3.7% | +22.8% | |
| May 30, 2023 | INVA Innoviva, Inc. | - | Buy | 200,000 | $13.04 | $2,608,707.00 | +2.9% | +1.2% | +18.3% | |
| May 18, 2023 | INVA Innoviva, Inc. | - | Buy | 60,000 | $13.07 | $784,228.00 | +0.9% | +2.8% | +21.1% | |
| May 11, 2023 | INVA Innoviva, Inc. | - | Buy | 290,000 | $12.34 | $3,577,411.00 | +4.4% | +9.9% | +25.5% | |
| Mar 10, 2021 | IRWD Ironwood Pharmaceuticals Inc | Director, 10% Owner | Buy | 225,000 | $10.38 | $2,335,500.00 | +1.4% | +3.0% | +5.3% | |
| Mar 5, 2021 | IRWD Ironwood Pharmaceuticals Inc | Director, 10% Owner | Buy | 775,000 | $10.01 | $7,758,750.00 | +5.0% | - | - | |
| Mar 2, 2021 | IRWD Ironwood Pharmaceuticals Inc | Director | Buy | 1,350,000 | $9.44 | $12,737,960.00 | +9.6% | - | - |